These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 445502)

  • 61. Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.
    Sessa C; Bolis G; Colombo N; D'Incalci M; Mermillod B; Valente I; Mangioni C
    Cancer Chemother Pharmacol; 1985; 14(3):222-8. PubMed ID: 3922639
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.
    Baak JP; Schipper NW; Wisse-Brekelmans EC; Ceelen T; Bosman FT; van Geuns H; Wils J
    Br J Cancer; 1988 May; 57(5):503-8. PubMed ID: 3395555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy.
    Ward B; Mather S; Shepherd J; Crowther M; Hawkins L; Britton K; Slevin ML
    Br J Cancer; 1988 Nov; 58(5):658-62. PubMed ID: 3219277
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer.
    Green JA; Warenius HM; Errington RD; Myint S; Spearing G; Slater AJ
    Br J Cancer; 1988 Nov; 58(5):635-9. PubMed ID: 3219276
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.
    Wright JC
    J Natl Med Assoc; 1988 May; 80(5):565-76. PubMed ID: 3047411
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment decisions in advanced ovarian cancer.
    Cody MM; Slevin ML
    Br J Cancer; 1989 Aug; 60(2):155-6. PubMed ID: 2669920
    [No Abstract]   [Full Text] [Related]  

  • 67. Surgical procedures for ovarian cancer.
    Shepherd JH; Crowther ME; Ward BG; Singh P
    Ann R Coll Surg Engl; 1986 Nov; 68(6):315-8. PubMed ID: 2434015
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer.
    Di Re F; Bohm S; Oriana S; Spatti GB; Zunino F
    Cancer Chemother Pharmacol; 1990; 25(5):355-60. PubMed ID: 2306797
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term survival in stage III and IV ovarian cancer.
    Petru E; Sevin BU; Averette HE; Koechli OR; Hilsenbeck S
    Arch Gynecol Obstet; 1991; 249(2):87-93. PubMed ID: 1953056
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancer.
    Lewis C; Lawson N; Rankin EM; Morrison G; MacLean AB; Cordiner J; Cassidy J; Kerr DJ; Kaye SB
    Cancer Chemother Pharmacol; 1990; 26(4):283-7. PubMed ID: 1695127
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.
    Griffiths CT; Parker LM; Fuller AF
    Cancer Treat Rep; 1979 Feb; 63(2):235-40. PubMed ID: 445502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
    Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
    Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
    Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.